In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference42 articles.
1. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver;de Jough;Gastroenterology,1992
2. Treatment of hepatocellular carcinoma;Bruix;Hepatology,1997
3. Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases;Feng;Chem Eng Sci,2003
4. Biomaterials in drug delivery and tissue engineering: One laboratory’s experience;Langer;Accounts Chem Res,2000
5. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo;Barraud;J Hepatol,2005
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chitosan nanoparticles, camel milk exosomes and/or Sorafenib induce apoptosis, inhibit tumor cells migration and angiogenesis and ameliorate the associated liver damage in Ehrlich ascites carcinoma-bearing mice;Beni-Suef University Journal of Basic and Applied Sciences;2024-08-02
2. A sustainable green-approach for biofabrication of chitosan nanoparticles, optimization, characterization, its antifungal activity against phytopathogenic Fusarium culmorum and antitumor activity;Scientific Reports;2024-05-17
3. Preparation, Characterization, and Anticancer Activity Assessment of Chitosan/TPP Nanoparticles Loaded with Echis carinatus Venom;Anti-Cancer Agents in Medicinal Chemistry;2024-04
4. “Drug-Free” chitosan nanoparticles as therapeutic for cancer treatment;Polymer Reviews;2024-03-08
5. Biogenic selenium nanoparticles and selenium/chitosan-Nanoconjugate biosynthesized by Streptomyces parvulus MAR4 with antimicrobial and anticancer potential;BMC Microbiology;2024-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3